Overlapping expression of serotonin transporters and neurokinin-1 receptors in posttraumatic stress disorder: a multi-tracer PET study

Ventromedial Prefrontal Cortex Is Critical for the Regulation of Amygdala Activity in Humans

(2015) Julian C. Motzkin et al.   BIOLOGICAL PSYCHIATRY

Differences in Anxiety-Like Behavior within a Batch of Wistar Rats Are Associated with Differences in Serotonergic Transmission, Enhanced by Acute SRI Administration, and Abolished By Serotonin Depletion

(2015) Jakob Näslund et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Serotonin Synthesis and Reuptake in Social Anxiety Disorder

(2015) Andreas Frick et al.   JAMA Psychiatry

Increased neurokinin-1 receptor availability in the amygdala in social anxiety disorder: a positron emission tomography study with [11C]GR205171

(2015) A Frick et al.   Translational Psychiatry

Effects of substance P and Sar-Met-SP, a NK1 agonist, in distinct amygdaloid nuclei on anxiety-like behavior in rats

(2014) Gabriel Shimizu Bassi et al.   NEUROSCIENCE LETTERS

The neurokinin-1 receptor antagonist aprepitant in co-morbid alcohol dependence and posttraumatic stress disorder: a human experimental study

(2014) Laura E. Kwako et al.   PSYCHOPHARMACOLOGY

Recent Progress in Understanding the Pathophysiology of Post-Traumatic Stress Disorder

(2013) Christopher R. Bailey et al.   CNS DRUGS

HIGHER IN VIVO SEROTONIN-1A BINDING IN POSTTRAUMATIC STRESS DISORDER: A PET STUDY WITH [11C]WAY-100635

(2013) Gregory M. Sullivan et al.   DEPRESSION AND ANXIETY

Mapping neurotransmitter networks with PET: An example on serotonin and opioid systems

(2013) Lauri Tuominen et al.   HUMAN BRAIN MAPPING

Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study

(2013) A Neumeister et al.   MOLECULAR PSYCHIATRY

In Search of the Trauma Memory: A Meta-Analysis of Functional Neuroimaging Studies of Symptom Provocation in Posttraumatic Stress Disorder (PTSD)

(2013) Gudrun Sartory et al.   PLoS One

Association of Posttraumatic Stress Disorder With Reduced In Vivo Norepinephrine Transporter Availability in the Locus Coeruleus

(2013) Robert H. Pietrzak et al.   JAMA Psychiatry

Chronic Antidepressant Treatment Impairs the Acquisition of Fear Extinction

(2012) Nesha S. Burghardt et al.   BIOLOGICAL PSYCHIATRY

Age, sex and NK1 receptors in the human brain — A positron emission tomography study with [11C]GR205171

(2012) Jonas Engman et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States

(2012) Ronald C. Kessler et al.   INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH

Biological studies of post-traumatic stress disorder

(2012) Roger K. Pitman et al.   NATURE REVIEWS NEUROSCIENCE

Psychiatric Comorbidity of Full and Partial Posttraumatic Stress Disorder Among Older Adults in the United States: Results From Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions

(2011) Robert H. Pietrzak et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

The Effect of Early Trauma Exposure on Serotonin Type 1B Receptor Expression Revealed by Reduced Selective Radioligand Binding

(2011) James W. Murrough   ARCHIVES OF GENERAL PSYCHIATRY

Reduced Amygdala Serotonin Transporter Binding in Posttraumatic Stress Disorder

(2011) James W. Murrough et al.   BIOLOGICAL PSYCHIATRY

Results From 2 Randomized, Double-Blind, Placebo-Controlled Studies of the Novel NK1 Receptor Antagonist Casopitant in Patients With Major Depressive Disorder

(2011) Emiliangelo Ratti et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Evidence for the differential co-localization of neurokinin-1 receptors with 5-HT receptor subtypes in rat forebrain

(2011) Sepehr Hafizi et al.   JOURNAL OF PSYCHOPHARMACOLOGY

A selective neurokinin-1 receptor antagonist in chronic PTSD: A randomized, double-blind, placebo-controlled, proof-of-concept trial

(2010) Sanjay J. Mathew et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Emotional processing in anterior cingulate and medial prefrontal cortex

(2010) Amit Etkin et al.   TRENDS IN COGNITIVE SCIENCES

Anxiolytic-like effects of the neurokinin 1 receptor antagonist GR-205171 in the elevated plus maze and contextual fear-potentiated startle model of anxiety in gerbils

(2009) Scott A. Heldt et al.   BEHAVIOURAL PHARMACOLOGY

Decreased Neurokinin-1 (Substance P) Receptor Binding in Patients with Panic Disorder: Positron Emission Tomographic Study with [18F]SPA-RQ

(2009) Yota Fujimura et al.   BIOLOGICAL PSYCHIATRY

Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorder

(2009) Johannes Tauscher et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

The Neurocircuitry of Fear, Stress and Anxiety Disorders

(2009) Lisa M Shin et al.   NEUROPSYCHOPHARMACOLOGY

Anxiety-like behavior is modulated by a discrete subpopulation of interneurons in the basolateral amygdala

(2009) W.A. Truitt et al.   NEUROSCIENCE

Human Fear Conditioning and Extinction in Neuroimaging: A Systematic Review

(2009) Christina Sehlmeyer et al.   PLoS One

Effects of Substance P in the Amygdala, Ventromedial Hypothalamus and Periaqueductal Gray on Fear-Potentiated Startle

(2008) Zuowei Zhao et al.   NEUROPSYCHOPHARMACOLOGY

Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET

(2007) Hristina Jovanovic et al.   NEUROIMAGE